Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women

NCT00186121 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Anastrozole (Arimidex)
DRUG: Goserelin (Zoladex)

Sponsor

Stanford University

Collaborators

[object Object]